文献速递慢性肾脏病

基于血清肌酐和胱抑素C估算全年龄段肾小球滤过率

Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

该研究基于血清胱抑素C分布定义归一化常数(年龄<70岁Q cysC=0.82 mg/L,年龄≥70岁Q cysC=0.95 mg/L),构建新的全年龄段胱抑素C方程(FAS cysC)和联合方程(FAS combi),并在11个队列共6132名白种受试者中验证。结果显示FAS cysC在儿童和老年人中优于对比方程,FAS combi在各年龄段均表现优异,FAS方程适用于所有年龄段及所有推荐肾生物标志物及其组合。

要点

  • FAS cysC方程在儿童中P30=86.1%,优于CAPA方程(76.6%)和Schwartz cysC方程(68.8%)。
  • FAS combi方程在儿童中P30=92.1%,优于所有方程。
  • FAS cysC在老年人中P30=88.2%,优于CKD-EPI cysC(84.4%)。

核心结论

  • FAS方程不仅适用于所有年龄段,也适用于所有推荐的肾脏生物标志物及其组合。

研究设计与样本

  • 基于血清胱抑素C分布评估定义归一化常数(年龄<70岁Q cysC=0.82 mg/L,年龄≥70岁Q cysC=0.95 mg/L),将FAS crea方程中的Scr/Q crea替换为ScysC/Q cysC或两种归一化生物标志物的平均值,得到FAS cysC和FAS combi方程。
  • 从11个不同队列收集实测GFR、Scr、ScysC、年龄、性别、身高和体重数据,共6132名独特白种受试者(368名儿童≤18岁,4295名成人,1469名老年人≥70岁)用于验证。

主要发现

  • 儿童和青少年中,FAS cysC方程P30=86.1%,优于CAPA方程(P30=76.6%;P < 0.0001)和基于ScysC的Schwartz方程(P30=68.8%;P < 0.0001);FAS combi方程P30=92.1%,优于所有方程(P < 0.0001)。
  • 成人中,FAS cysC方程(P30=82.6%)与CKD-EPI cysC方程(P30=80.4%)表现相当;FAS combi方程(P30=89.9%)与联合CKD-EPI方程(P30=88.2%)相当。
  • 老年人中,FAS cysC(P30=88.2%)优于CKD-EPI cysC(P30=84.4%;P < 0.0001);FAS combi方程(P30=91.2%)显著优于联合CKD-EPI方程(P30=85.6%)(P < 0.0001)。

关键数值与推荐

  • FAS cysC归一化常数:年龄<70岁Q cysC=0.82 mg/L,年龄≥70岁Q cysC=0.95 mg/L。
  • 儿童中FAS cysC的P30=86.1%,CAPA方程P30=76.6%(P < 0.0001),Schwartz cysC方程P30=68.8%(P < 0.0001),FAS combi P30=92.1%(P < 0.0001)。
  • 成人中FAS cysC P30=82.6%,CKD-EPI cysC P30=80.4%;FAS combi P30=89.9%,联合CKD-EPI P30=88.2%。
  • 老年人中FAS cysC P30=88.2%,CKD-EPI cysC P30=84.4%(P < 0.0001);FAS combi P30=91.2%,联合CKD-EPI P30=85.6%(P < 0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We recently published and validated the new serum creatinine (Scr)-based full-age-spectrum equation (FAS crea ) for estimating the glomerular filtration rate (GFR) for healthy and kidney-diseased subjects of all ages. The equation was based on the concept of normalized Scr and shows equivalent to superior prediction performance to the currently recommended equations for children, adolescents, adults and older adults. METHODS: Based on an evaluation of the serum cystatin C (ScysC) distribution, we defined normalization constants for ScysC ( Q cysC = 0.82 mg/L for ages <70 years and Q cysC = 0.95 mg/L for ages ≥70 years). By replacing Scr/ Q crea in the FAS crea equation with ScysC/ Q cysC , or with the average of both normalized biomarkers, we obtained new ScysC-based (FAS cysC ) and combined Scr-/ScysC-based FAS equations (FAS combi ). To validate the new FAS cysC and FAS combi we collected data on measured GFR, Scr, ScysC, age, gender, height and weight from 11 different cohorts including n = 6132 unique white subjects (368 children, aged ≤18 years, 4295 adults and 1469 older adults, aged ≥70 years). RESULTS: In children and adolescents, the new FAS cysC equation showed significantly better performance [percentage of patients within 30% of mGFR (P30) = 86.1%] than the Caucasian Asian Paediatric Adult Cohort equation (P30 = 76.6%; P < 0.0001), or the ScysC-based Schwartz equation (P30 = 68.8%; P < 0.0001) and the FAS combi equation outperformed all equations with P30 = 92.1% (P < 0.0001). In adults, the FAS cysC equation (P30 = 82.6%) performed equally as well as the Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI cysC ) (P30 = 80.4%) and the FAS combi equation (P30 = 89.9%) was also equal to the combined CKD-EPI equation (P30 = 88.2%). In older adults, FAS cysC was superior (P30 = 88.2%) to CKD-EPI cysC (P30 = 84.4%; P < 0.0001) and the FAS combi equation (P30 = 91.2%) showed significantly higher performance than the combined CKD-EPI equation (P30 = 85.6%) (P < 0.0001). CONCLUSION: The FAS equation is not only applicable to all ages, but also for all recommended renal biomarkers and their combinations.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Pottel H, Delanaye P, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017. PMID: 28089986. doi:10.1093/ndt/gfw425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。